Stella Pharma Corporation
JPX: 4888.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Koki Uehara
- Employees
- 44
- Headquarters
- Osaka, Japan
- IPO year
- 2021
- Market cap
- ¥18B
- Website
- https://www.stella-pharma.co.jp
Loading 4888…
Loading profile data…Frequently asked questions about 4888
What does Stella Pharma Corporation (4888.T) do?
Stella Pharma Corporation engages in the research, development, manufacturing, and distribution of pharmaceuticals. The company develops drugs for boron neutron capture therapy (BNCT). Its product includes SPM-011, a boron-containing drug for BNCT used for treating head and neck cancer, recurrent malignant glioma and meningioma, and malignant me...
Where does 4888.T trade?
Stella Pharma Corporation (4888.T) trades on the Tokyo Stock Exchange.
What sector is 4888.T in?
Stella Pharma Corporation (4888.T) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Stella Pharma Corporation?
Koki Uehara is the chief executive officer of Stella Pharma Corporation (4888.T).
Where is Stella Pharma Corporation headquartered?
Stella Pharma Corporation is headquartered in Japan.
Does 4888.T pay a dividend?
Stella Pharma Corporation (4888.T) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4888.T go public?
Stella Pharma Corporation (4888.T) completed its initial public offering in 2021.